A warm welcome to Valli Pollisetty, our newest member of the OMNI team at LARVOL!
#NewTeamMember #LARVOL
Follow
LARVOL
@Larvol
We provide accurate, rapid, expertly-curated information to enable strategic decision-making for top pharma and life science companies. #VRfirst #RemoteAlways
LARVOL’s Tweets
Wondering which #oncology conferences to go to this year? Well, look no further as we bring you our monthly view of the top conferences for 2023.
Don't forget to purchase your CONF planner when attending #conferences 👉 larvol.com/solutions/conf
#PrecisionMedicine #conference
Here's a taster of the content available from the NSCLC Pipeline report from LARVOL PULSE.
Fancy a more comprehensive look? 👀
Comment below or click to arrange a demo👇 larvol.com/solutions/puls
#pipeline #pharma #drugdiscovery #clinicaltrials #clinicalresearch #oncologist
3
2
Missed out on last week's top oncology news?
Catch up now with CLIN.
Try it out for free 👉 bit.ly/3OxnaMc
#oncology #oncologynews #clinicaltrialnews #pharmaceutical #biotechnology
1
This week's top liquid tumor poll comes to us from .
The results are in. Did you vote?
#Oncology #OncoTwitter
bit.ly/3RgDJgz
1
Here's a look at the top #PrecisionMedicine updates from this week!
PULSE filters news based on novelty, relevance, and impact with an additional layer of expert analysis.
Request a demo here 👉 bit.ly/3goXLHE
#oncology #PrecisionOncology #cancerresearch #cancer
2
1
This week's top solid tumor poll comes to us from .
There's still 1 hour left, so get involved! 🙌
twitter.com/esinghimd/stat
#oncology #oncoalert #CancerResearch
Quote Tweet
@US_FDA approves pembrolizumab for adjuvant treatment after resection & platinum-based chemo for stage IB (T2a ≥4 cm), II-IIIA NSCLC, per KEYNOTE-091
irrespective of PD-L1 expression, despite subset data
#lcsm, what is our take-away & what to do in clinic? @OncoAlertShow this poll
1
1
3
Had a blast celebrating Happy Hour in the metaverse with the team at LARVOL! So grateful to be a part of such an innovative and fun-loving group. Cheers to many more virtual adventures to come!
#HappyHour #LARVOL #Metaverse
1
3
The 5th & last synthesis from ASCO GI 23 is now available on our website. Head over to bit.ly/3Jeymg8 to discover the emerging themes and trends identified by our friends at . Don't miss out on this valuable insight! #ASCO #GI23 #oncology
2
Newly available: the fourth expert synthesis from ASCO GI23, brought to you by our friends at is now on our website. Dive into reactions & read the full review at bit.ly/3kznUFv.
#ASCO #GI23 #oncology
1
2
Just released: the third expert synthesis from ASCO GI23, brought to you by our partners at is now available on our website. Get a comprehensive overview of reactions & read the full review at bit.ly/3Hs0ZVQ. #GI23 #oncology #expertreview #blog
1
2
Just in: the top 5 abstracts from ASCO #GI23 are now available.
Check out how opinions & reactions evolved during the conference by comparing our pre-conference top 5 list. See which abstracts made the cut & how they were received.
#ASCO #GI23 #abstracts #oncology #conference
1
3
The second in our ASCO GI '23 expert syntheses, powered by our friends at has gone live.
Read it here 👉bit.ly/3j3EX1Y
#GI23 #Oncology #CancerResearch
3
3
We've just published the first in a series of expert syntheses from ASCIO GI 23, powered by our friends at . In this post, we explore the reaction to abstract #358, INFINITY.
Read more 👉 bit.ly/3H1qEmv
#GI32 #oncology #onco #CancerResearch
4
3
Here's a look at the top #PrecisionMedicine updates from last week!
PULSE filters news based on novelty, relevance, and impact with an additional layer of expert analysis.
Request a demo here 👉 bit.ly/3goXLHE
#oncology #PrecisionOncology #cancerresearch #cancer
2
1
This week's liquid tumor poll comes to us from . Thanks for creating awesome content for the #oncology community.
Quote Tweet
Follow-up poll since now I'm very curious!!
ASCT-eligible patient with standard-risk #MMsm, achieves a PR (M-spike 4.2 --> 1.6) after 5 cycles of Dara-VRd. Cells collected 
.
ASCT now, try to deepen response first (e.g., Kyprolis or Pomalyst), or adjudicate based on BMBx PC%?
.
ASCT now, try to deepen response first (e.g., Kyprolis or Pomalyst), or adjudicate based on BMBx PC%?Show this poll
1
This week's top solid tumor poll is from and with one day left, there's still time to vote 👇👇
Quote Tweet
#OncTwitter #PancreaticCancer
Hi all - I have another
for your guidance
O/W healthy patient w/ known Lynch Synd.
Had
for CRC; recurrence Txed for 2 y w/ pembro - NED 5y
Now has an operable PDAC Bx proven
3 mos of pembro & the lesion is not visible on 
Would you:
for your guidance
O/W healthy patient w/ known Lynch Synd.
Hadfor CRC; recurrence Txed for 2 y w/ pembro - NED 5y
Now has an operable PDAC Bx proven
3 mos of pembro & the lesion is not visible on
Would you:Show this poll
1
3
Want a comprehensive view of trial activity in your disease area? PULSE heatmaps offer a visual representation of trials based on conditions, MOAs, and biomarkers.
Try it out now 👉 bit.ly/3GKVqQs #heatmaps #diseasearea #trials #marketintelligence #healthcare
1
Stay ahead of the game with PULSE's cancer vaccine pipeline.
Get an in-depth look at the current state of the market and stay informed.
Don't miss out on this invaluable resource 👉bit.ly/3GKVqQs
#cancervaccine #marketintelligence #biotechnology
2
3
Mark Takata's talk to LARVOL Emerging Leaders
2
Attending #GI23 today?
Make sure you're up-to-date on the top 5 most talked about abstracts before the conference starts, brought to you by CLIN.
Want more insight? Head to CLIN 👉 bit.ly/3GRZmzc
#ASCOGI #oncology #oncologynews #pharmaceutical #biotechnology
1
Missed out on last week's top oncology news? Catch up now with CLIN, the ultimate resource of cancer trial data & see what your peers have to say.
Try it out for free 👉 bit.ly/3OxnaMc
#oncology #oncologynews #clinicaltrialnews #pharmaceutical #biotechnology
1
1
👉 Here's the top liquid tumor #oncology poll of the week coming from .
If you want to explore more conversations, CLIN covers them all and is free to use. Try CLIN at bit.ly/3cip6ck
#liquidtumor #medtwitter
Quote Tweet
#MMsm poll h/t @BoWangMD1!
ASCT-eligible MM where 1st-line Dara-VRd "quiet quit" - response got stuck at PR, and so you switched to 2nd-line CD38-Kd to successfully deepen to ≥VGPR. Not truly len-refractory per se.
What post-ASCT maintenance would you use?
Show this poll
1
3
👉 Here's the top solid tumor #oncology poll of the week coming from .
If you want to explore more conversations, CLIN covers them all and is free to use. Try CLIN at bit.ly/3cip6ck
#solidtumor #medicine
Quote Tweet
Hey #lcsm precision onc guru friends- you want to be an Alkemist and help w challenging case?
Young pt w egfr ex19 del, nice response to osi for yr+, now progression incl CNS
CNS specimen now shows STRN-ALK fusion along w ex19del. Getting SRS to resid CNS dx
What is best syst tx?
Show this poll
1
If you missed yesterday's episode of LARVOL & friends featuring discussing Health Innovation & the Future, you can catch up here 👉 bit.ly/3kfbpyY
And don't forget to tune in on Tuesdays at 6:30 am PST for more episodes!
#healthinnovation #thefutureofhealth
1
4
4
Innovation without the human connection to address people's needs falls flat! Amazing talk with 's and on the power of #empathy in #healthinnovation!
We even bring out our #AppleNewtons! #AI #AR #VR #JPM23
LISTEN: twitter.com/i/broadcasts/1
4
18
68
Looking for a market intelligence solution that's tailored to your disease area? PULSE offers heatmaps customized based on conditions, mechanisms of action, and biomarkers.
Check it out with a demo 👉 bit.ly/3goXLHE.
#marketintelligence #healthcare #biotechnology
2
2
Here's a sneak peek into our COPD pipeline data via PULSE.
Want more info like this? Drop us a line for a demo 👉 bit.ly/3goXLHE
#COPD #lungdisease #respiratoryillness #breathingproblems #lunghealth #lungawareness #respiratoryhealth #lungs #respiratorydisease
1
2
Missed out on last week's top oncology news? Catch up now with CLIN, the ultimate ecosystem of cancer trial data & see what your peers have to say.
Try it out for free 👉 bit.ly/3OxnaMc
#oncology #oncologynews #clinicaltrialnews #pharmaceutical #biotechnology
1
2
👉 Check out the top #liquidtumor poll of the week with a total of 1,195 votes! Thanks
#oncology #medtwitter
Quote Tweet
How would you treat DLBCL edition!
A 50 yo patient presents with a left parotid mass. Biopsy is consistent with DLBCL, germinal center subtype.
PET/CT is unrevealing other than left parotid mass.
ECOG = 0
LDH = normal
FISH panel = MYC and BCL2 rearrangements!
Show this poll
1
2
👉 Here's the top solid tumor #oncology poll of the week coming from .
If you want to explore more conversations, CLIN covers them all and is free to use. Try CLIN at bit.ly/3cip6ck
#solidtumor #medicine
Quote Tweet
Teaser from our upcoming Hawaii Lung meeting. 58 yo man with stage II (pT1cN1M0) lung adenoca, s/p surgical resection after neo-adj nivo-chemo (CM816) What to do post-op? Register at event.gotoper.com/event
Show this poll
2
2
Welcome to the team, Vinayaka, Amana, and Aparna! We're excited to have you join us and can't wait to see what you'll accomplish. Welcome aboard!
#newteammembers #LARVOL
1
From our tribe to yours, we wish you a very happy, healthy and prosperous New Year!
We look forward to continued friendships and new partnerships in the year ahead.
1
4